[Clinical observation on treatment of functional dyspepsia by injection of vitamin B1 into Zusanli (ST36) and Hegu (LI4)]

Zhen Ci Yan Jiu. 2021 Dec 25;46(12):1043-7. doi: 10.13702/j.1000-0607.20210660.
[Article in Chinese]

Abstract

Objective: To observe the effect and safety of injection of vitamin B1 into Zusanli (ST36) and Hegu (LI4) in the treatment of functional dyspepsia (FD).

Methods: A total of 100 FD patients were equally divided into medication group and acupoint injection group (n=50/group) according to a random number table. Patients in the medication group were ordered to take mosapride citrate tablets (5 mg) orally 30 min before each of the three meals, while those in the acupoint injection group received injection of vitamin B1 into ST36 and LI4, once every other day, three times a week. One week later, the clinical symptom scores, total effective rates, serum gastrin (GAS) and plasma motilin (MTL) contents, and gastric emptying rates between the two groups were compared, followed by the observation of adverse reactions. Two weeks' follow-up survey was conducted after the end of treatment, and the clinical symptom scores and total effective rates of the two groups were further compared.

Results: Compared with the data before treatment in the same one group, the clinical symptom scores and serum GAS contents of post-treatment as well as the follow-up symptom scores were all significantly decreased (P<0.05,P<0.01), while the plasma MTL levels and gastric emptying rates were obviously increased in both groups (P<0.01). Comparison between the two groups showed that the clinical symptom score, serum GAS content after the treatment and follow-up symptom score were considerably lower (P<0.01), but the total effective rate, plasma MTL, gastric emptying rate after the treatment and total effective rate of follow-up notably higher in the acupoint injection group than those in the medication group (P<0.01,P<0.05).

Conclusion: Injection of vitamin B1 into ST36 and LI4 is effective in improving symptoms of PD patients, which may be related to its functions in regulating the levels of GAS and MTL in blood, and facilitating gastrointestinal motility.

目的:观察足三里、合谷穴位注射维生素B1治疗功能性消化不良(FD)的疗效及安全性。方法:选择FD患者100例,按照随机数字表法分为西药组和穴位注射组,每组50例。西药组于每日三餐前30 min口服枸橼酸莫沙必利片5 mg,共1周;穴位注射组给予足三里、合谷穴位注射维生素B1,隔日1次,共3次。1周后比较两组临床症状积分、总有效率、血清胃泌素(GAS)含量、血浆胃动素(MTL)含量及胃排空率,观察两组患者的不良反应。结束治疗后2周随访,比较两组临床症状积分及总有效率。结果:与本组治疗前比较,两组治疗后、随访时临床症状积分、血清GAS含量均降低(P<0.05,P<0.01),血浆MTL含量、胃排空率升高(P<0.01)。与西药组比较,穴位注射组治疗后、随访时临床症状积分、血清GAS含量降低(P<0.01),血浆MTL含量、胃排空率升高(P<0.01)。穴位注射组治疗后、随访时总有效率分别为91.84%(45/49)、93.88%(46/49),西药组治疗后、随访时总有效率分别为75.51%(37/49)、77.55%(38/49),穴位注射组临床疗效优于西药组(P<0.05)。结论:足三里、合谷穴位注射维生素B1治疗FD疗效显著,机制可能与其调节胃肠道激素GAS、MTL含量,增强胃肠动力有关。.

Keywords: Acupoint injection; Functional dyspepsia; Hegu (LI4); Vitamin B1; Zusanli (ST36).

MeSH terms

  • Acupuncture Points
  • Acupuncture Therapy*
  • Dyspepsia* / drug therapy
  • Humans
  • Motilin
  • Thiamine

Substances

  • Motilin
  • Thiamine